Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Priority to MA33531ApriorityCriticalpatent/MA33960B1/en
Publication of MA33960B1publicationCriticalpatent/MA33960B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
LA PRÉSENTE INVENTION A POUR OBJET DES DÉRIVÉS DE DÉRIVÉS DE 4{2-[PHÉNYL-3,6- DIHYDRO-PYRIDIN-1 YL]-2-OXO-ALKYL}-1 -PIPÉRAZIN-2-ONE ET 4-{2-[PHÉNYL-2,5-DIHYDRO-PYRROL-1 - YL]-2-OXO-ALKYL}-1 -PIPÉRAZIN-2-ONE DE FORMULE GÉNÉRALE (I) DANS LAQUELLE A, B, M, R3 ET N SONT DÉFINIS COMME EN REVENDICATION 1, LEUR PRÉPARATION ET LEUR APPLICATION EN THÉRAPEUTIQUE.The subject of the present invention is derivatives of 4 {2- [phenyl-3,6-dihydro-pyridin-1-yl] -2-oxo-alkyl] -1-piperazin-2-one derivatives and 4- [PHENYL-2,5-DIHYDRO-PYRROL-1-YL] -2-OXO-ALKYL} -1-PIPERAZIN-2-ONE OF THE GENERAL FORMULA (I) IN WHICH A, B, M, R3 AND N ARE DEFINED AS CLAIM 1, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS.
MA33531A2011-01-172011-01-17
2-OXO-ALKYL-1-PIPERAZIN-2-ONE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
MA33960B1
(en)